Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MESH: Feces/chemistry"'
Autor:
Jean de Gunzburg, Violaine Augustin, Amine Ghozlane, Laurence Armand-Lefevre, Xavier Duval, Antoine Andremont, Frédérique Sablier-Gallis, Sean Kennedy, Annie Ducher, Marina Varastet, Loubna Alavoine, Nicolas Pons, Elisabeth Chachaty, Florence Levenez, Charles Burdet, Etienne Ruppé
Publikováno v:
Journal of Infectious Diseases
Journal of Infectious Diseases, 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
The Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
Journal of Infectious Diseases 4 (217), 628-636. (2018)
Journal of Infectious Diseases, 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
The Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
Journal of Infectious Diseases 4 (217), 628-636. (2018)
In a phase 1 clinical study, coadministration of the adsorbent-based DAV132 product together with the fluoroquinolone antibiotic moxifloxacin, while not affecting the plasma concentrations of the antibiotic, reduced by >99% exposure of the intestinal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72129e0df637086bfb515cf4f8d8b31f
https://hal-pasteur.archives-ouvertes.fr/pasteur-02552147/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-02552147/document
Autor:
Bernd Carsten Stahl, Jean-Luc Desseyn, Marie-Odile Husson, Frédéric Gottrand, Henry Bernard, Nana Bartke
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2015, 10 (11), pp.e0139686. ⟨10.1371/journal.pone.0139686⟩
PLoS ONE, Vol 10, Iss 11, p e0139686 (2015)
PLoS ONE, 2015, 10 (11), pp.e0139686. ⟨10.1371/journal.pone.0139686⟩
PLoS ONE, Public Library of Science, 2015, 10 (11), pp.e0139686. ⟨10.1371/journal.pone.0139686⟩
PLoS ONE, Vol 10, Iss 11, p e0139686 (2015)
PLoS ONE, 2015, 10 (11), pp.e0139686. ⟨10.1371/journal.pone.0139686⟩
International audience; The administration of prebiotics as oligosaccharides (OS), by acting on intestinal microbiota, could modulate the immune and inflammatory response and represent a new strategy to improve the outcome of bacterial infection. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e8d996f4d3641c4c4d72187eaa8670
https://hal.univ-lille.fr/hal-02178904
https://hal.univ-lille.fr/hal-02178904